MESOMesoblast Limited Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $14.76 (+0.37% today)

Market Cap: $1.91B

P/E (TTM): -24.00

Relative Strength (RS%): 61

-31.3% from 52-week high

Back to Scanner

MESO

NASDAQRS 61Score 14

Mesoblast Limited

HealthcareBiotechnology$1.91B
$14.76
+0.4% ($0.05)
-31.3% from 52W High
P/E (TTM)
-24.00
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
-218.7%
ROE
-14.0%
D/E
0.24
Div Yield
0.0%
Avg Volume
173.2K

Price Chart

Key Levels

SMA 200
$15.91
SMA 50
$16.15
Price
$14.76
52W High
$21.48

Setup Radar

0/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst